Coordinated Specialty Care (CSC) for Schizophrenia

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Schizophrenia+4 MoreCoordinated Specialty Care (CSC) - Other
Eligibility
16 - 35
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare the effects of two types of cancer support services on engagement and outcomes.

Eligible Conditions
  • Schizophrenia
  • Schizoaffective Disorder
  • Schizophreniform Disorder
  • Bipolar Disorder With Psychotic Features
  • Major Depressive Disorder with Psychotic Features

Treatment Effectiveness

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: 12 months

12 months
Annualized hospitalization rates
Number of participants hospitalized
Symptom and functioning outcomes assessed by the MIRECC-GAF
Time (days) to first hospitalization

Trial Safety

Trial Design

2 Treatment Groups

CSC-TH
1 of 2
CSC-SD
1 of 2

Experimental Treatment

Non-Treatment Group

180 Total Participants · 2 Treatment Groups

Primary Treatment: Coordinated Specialty Care (CSC) · Has Placebo Group · N/A

CSC-TH
Other
Experimental Group · 1 Intervention: Coordinated Specialty Care (CSC) · Intervention Types: Other
CSC-SD
Other
PlaceboComparator Group · 1 Intervention: Coordinated Specialty Care (CSC) · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months

Who is running the clinical trial?

University of MichiganOTHER
1,634 Previous Clinical Trials
6,415,148 Total Patients Enrolled
6 Trials studying Schizophrenia
535 Patients Enrolled for Schizophrenia
Tulane UniversityOTHER
94 Previous Clinical Trials
227,700 Total Patients Enrolled
Yale UniversityOTHER
1,680 Previous Clinical Trials
21,088,079 Total Patients Enrolled
56 Trials studying Schizophrenia
3,522 Patients Enrolled for Schizophrenia
Northwestern UniversityOTHER
1,457 Previous Clinical Trials
789,789 Total Patients Enrolled
11 Trials studying Schizophrenia
1,965 Patients Enrolled for Schizophrenia
University of RochesterOTHER
792 Previous Clinical Trials
501,704 Total Patients Enrolled
1 Trials studying Schizophrenia
180 Patients Enrolled for Schizophrenia
National Institute of Mental Health (NIMH)NIH
2,559 Previous Clinical Trials
1,823,421 Total Patients Enrolled
229 Trials studying Schizophrenia
87,554 Patients Enrolled for Schizophrenia
Vanderbilt UniversityOTHER
685 Previous Clinical Trials
6,134,490 Total Patients Enrolled
9 Trials studying Schizophrenia
1,675 Patients Enrolled for Schizophrenia
Indiana UniversityLead Sponsor
877 Previous Clinical Trials
759,375 Total Patients Enrolled
14 Trials studying Schizophrenia
842 Patients Enrolled for Schizophrenia
Alan BreierPrincipal InvestigatorIndiana Univeristy

Eligibility Criteria

Age 16 - 35 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are between 16 and 35 years of age.